G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 1.8 GBX Market Closed
Market Cap: 5.2m GBX

Operating Margin
Genincode PLC

-184.6%
Current
-334%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-184.6%
=
Operating Profit
-5m
/
Revenue
2.7m

Operating Margin Across Competitors

Genincode PLC
Glance View

Market Cap
5.2m GBX
Industry
Health Care

GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.

GENI Intrinsic Value
2.8 GBX
Undervaluation 36%
Intrinsic Value
Price
G
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-184.6%
=
Operating Profit
-5m
/
Revenue
2.7m
What is the Operating Margin of Genincode PLC?

Based on Genincode PLC's most recent financial statements, the company has Operating Margin of -184.6%.

Back to Top